Financials

  • Market Capitalization 251.16 M
  • Employee 35
  • Founded 2008
  • CEO N/A
  • Website www.inhibikase.com
  • Headquarter Delaware, United States
  • FIGI BBG005TP2339
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.18
市销率
53.93

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3359
NAUT
Nautilus Biotechnology, Inc. - Common Stock
2.03 USD-6.45%+10.93%+100.99%+123.08%258.33 M USD
3368
IPSC
Century Therapeutics, Inc. - Common Stock
1.40 USD-2.78%+2.94%-28.57%+154.55%253.51 M USD
3389
RCKT
Rocket Pharmaceuticals, Inc. - Common Stock
2.26 USD-8.87%-9.24%-31.31%-42.35%248.09 M USD
3394
ACIU
AC Immune SA - Common Stock
2.42 USD-1.22%-4.35%-11.36%-29.45%246.22 M USD

新闻